Phase 2 Readout~quarter

Phase 2 Readout: sls009

Drug
sls009
Indication
newly diagnosed, high‑risk acute myeloid leukemia

Other upcoming events for SLS

Phase 3 ReadoutPhase 3 Topline: A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monoth

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: sls009 — SLS Phase 2 Readout | BioSniper